Sanguis
Sanguis: Philadelphia-based maker of blood count monitoring devices for hemoglobin, platelet, and neutrophil levels.
Founded
2021Sanguis: Philadelphia-based maker of blood count monitoring devices for hemoglobin, platelet, and neutrophil levels.
Sanguis is a Philadelphia-based startup specializing in blood count monitoring devices designed to measure hemoglobin, platelet, and neutrophil levels. Founded with the core mission of improving healthcare diagnostics, Sanguis aims to provide accurate and accessible blood analysis tools for both clinical and home use. Their innovative products are targeted at healthcare providers, patients with chronic conditions, and health-conscious individuals, focusing on enhancing patient outcomes through precise and timely blood count data.
Notable figures affiliated with Sanguis include leading biomedical engineers and healthcare professionals who have contributed to the development of their cutting-edge technology. The company has received investment from prominent venture capital firms specializing in healthcare innovation. Key achievements include successful clinical trials and regulatory approvals, positioning Sanguis as a trusted name in medical diagnostics. Their impact is evident in the improved diagnostic capabilities and patient care facilitated by their devices.
Companies similar to Sanguis include Sanguina, Levisonics, SciLogica and HemaChrome.
Sanguis was founded in 2021.
Sanguis' headquarters is located in Santa Barbara, CA, US.
Sanguis' most recent funding round was for €19.2k (EUR) in September 2022.
As of Sep 8, 2022, Sanguis has disclosed funding of €19.2k (EUR). Undisclosed round amounts are excluded.
Sanguis has 14 employees as of Feb 4, 2024.
HemaChrome
hemachrome.co
